SEC Form 4 · accession 0001209191-18-031475
CUMBERLAND PHARMACEUTICALS INC · CPIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Bonner
Officer — Chief Financial Officer
Period of report
May 17, 2018
Accepted (ET)
May 18, 2018 · 5:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001087294
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 17, 2018 | P | 400 | $6.12 | A | 18,054 | D |
Table II — derivative securities
No Table II lines on this filing.